RNU7-188P

Across TCGA pan-cancer cohorts, RNU7-188P RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RNU7-188P data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher RNU7-188P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU7-188P expression acts as an unfavorable survival marker.

LIHC, DLBC, and ESCA are the cancer types where RNU7-188P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Tertile	All	0.045	0.553	<.001	45	view →
DLBC	DFS	Tertile	II,III,IV	0.022	0.837	<.001	36	view →
ESCA	OS	Tertile	All	0.205	0.911	<.001	36	view →
KIRC	DFS	Tertile	IV	0.193	0.511	.044	18	view →
LGG	DFS	Tertile	All	0.190	0.753	.002	18	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RNU7-188P–LIHC (DFS)

Open the LIHC breakdown →